Tier 2 — strong
Coenzyme Q10 supplementation in rheumatic diseases: A systematic review
Clinical Nutrition ESPEN
2024
59:63-69
Bibliography
- PubMed
- PMID 38220408
- Funding
- Not reported in the accessible PubMed abstract.
- Competing interests
- Not reported in the accessible PubMed abstract.
Study snapshot
| Design | Systematic review |
|---|---|
| Model | Human rheumatic-disease studies |
| Sample | 20 articles; 483 patients |
| Intervention | CoQ10 supplementation across fibromyalgia, rheumatoid arthritis and antiphospholipid syndrome studies |
| Duration | Varied across included studies |
| Endpoints | Fibromyalgia pain and fatigue; Sleep and mood; Fibromyalgia Impact Questionnaire; Rheumatoid arthritis disease activity; Inflammatory and oxidative-stress biomarkers; Endothelial/prothrombotic markers |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- CoQ10 for Fibromyalgia: Pain, Fatigue & What Human Studies ShowDoes CoQ10 help fibromyalgia? Review the small CoQ10 trial, 2024 systematic review and 2025 combination RCT for pain, fatigue, sleep and Fibromyalgia...Read analysis
- CoQ10 Benefits: What Human Studies Actually ShowCoQ10 benefits ranked by human evidence: heart failure, migraine, fatigue, blood pressure, metabolism, fertility, statins, exercise and where claims remain unproven.Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



